Daiichi Sankyo Targets US Oncology Market with US$935 M Plexxikon Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 3 (Table of Contents)
Published: 17 Mar-2011
DOI: 10.3833/pdr.v2011.i3.1446 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Daiichi Sankyo has agreed to buy Plexxikon for up to US$935 M in what is yet another example of an overseas acquisition by a Japanese pharmaceutical company looking to prosper in the US oncology market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS